Quent Capital’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Other funds holding KPTI
ACA
Quent Capital's KPTI Position: Q3 2026 in Review
Quent Capital held its Karyopharm Therapeutics (KPTI) position steady in Q3 2026 at 166 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #1634.
Quent Capital first reported a position in KPTI in Q1 2022 and has held it in 14 quarters since. The position peaked at $3.03K in Q2 2024. 92 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.
- Quent Capital held 166 shares of Karyopharm Therapeutics worth $203 as of Q3 2026.
- Quent Capital left its Karyopharm Therapeutics share count unchanged in Q3 2026.
- Karyopharm Therapeutics made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1634 holding.
- Quent Capital first reported a position in Karyopharm Therapeutics in Q1 2022 and has held it in 14 quarters since.
- Quent Capital's Karyopharm Therapeutics position peaked at $3.03K in Q2 2024.
- 92 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.
Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.